HRT Financial’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-31,266
| Closed | -$2.29M | – | 2521 |
|
|
2024
Q1 | $2.29M | Buy |
+31,266
| New | +$2.29M | 0.01% | 500 |
|
|
2023
Q2 | – | Sell |
-8,872
| Closed | -$652K | – | 2689 |
|
|
2023
Q1 | $652K | Sell |
8,872
-22,548
| -72% | -$1.66M | 0.01% | 1114 |
|
|
2022
Q4 | $2.1M | Buy |
31,420
+10,092
| +47% | +$674K | 0.03% | 543 |
|
|
2022
Q3 | $1.15M | Buy |
+21,328
| New | +$1.15M | 0.01% | 802 |
|
|
2022
Q1 | – | Sell |
-16,171
| Closed | -$1.56M | – | 3203 |
|
|
2021
Q4 | $1.56M | Buy |
+16,171
| New | +$1.56M | 0.01% | 704 |
|
|
2021
Q2 | – | Sell |
-15,184
| Closed | -$1.44M | – | 3071 |
|
|
2021
Q1 | $1.44M | Buy |
+15,184
| New | +$1.44M | 0.01% | 698 |
|
|
2020
Q3 | – | Sell |
-3,616
| Closed | -$252K | – | 2052 |
|
|
2020
Q2 | $252K | Buy |
+3,616
| New | +$252K | 0.01% | 941 |
|
|
2019
Q4 | – | Sell |
-3,358
| Closed | -$208K | – | 1354 |
|
|
2019
Q3 | $208K | Sell |
3,358
-7,736
| -70% | -$479K | 0.01% | 1020 |
|
|
2019
Q2 | $790K | Buy |
+11,094
| New | +$790K | 0.05% | 295 |
|